HEALTH QUESTIONS / 01–04
What have studies shown for these health concerns?
Studies have found different answers about weight, skin, energy, and interest in sex. Peptides join amino acids, the small parts from which proteins are made. Your health question determines which findings may be useful.
Semaglutide
Semaglutide imitates GLP-1, a gut hormone that sends messages after meals. Studies measured weight loss and counted serious illness involving the heart and kidneys.
Check weight and illness findings 01 ›
GHK-Cu
GHK-Cu contains copper held by small protein parts. Cream studies have reported skin changes, but strong evidence of benefits for people remains limited.
Check cream and hair findings 02 ›
NAD+
Cells need NAD+ to get energy from food. Supplements may increase NAD+ in blood without proving that people feel better or live longer.
Check NAD+ supplement results 03 ›
PT-141
A medicine for certain women distressed by lost sexual desire. The approved use is narrow, and heart health affects whether treatment is safe.
Check desire findings and risks 04 ›Shows which health problem each substance was tested for
What do these studies say about better health? The answers depend on the problem studied, rather than the word “peptide.” Semaglutide has large studies of weight loss, heart disease, and kidney disease. GHK-Cu has smaller studies testing changes in skin, with less certain results. Cells need NAD+, but related supplements have not proved broad gains in health. PT-141 was tested for lasting, troubling loss of interest in sex. The four substances were studied for different problems, so their results aren't interchangeable.
Your symptoms matter more than a general promise that a substance helps.
A doctor can begin with weight, a skin problem, tiredness, or low desire. Each concern calls for its own questions, examination, and sometimes blood tests. Earlier illness and current medicines may change how the doctor understands a symptom. A useful study includes people with a similar concern. Tests on cells alone cannot explain why you feel unwell.
Checks whether a treatment helped people feel or stay well
A useful finding describes what changed for the people who received treatment. Semaglutide studies measured weight and counted serious illness involving kidneys and the heart [2][3]. GHK-Cu studies examined skin repair, but getting the ingredient through skin remains difficult [8]. A review found little firm evidence that NAD+ supplements improved people's health [13]. PT-141 studies asked women about troubling loss of desire and any improvement [19][20]. Those findings answer particular health questions, rather than every claim made for these substances.
Your doctor can compare a promised benefit with the change a study actually measured.
A lower weight, fewer illnesses, and more NAD+ in blood mean different things. Your blood test may change without you feeling any better. The doctor can check whether a treatment is approved for the proposed use. The people's earlier health and any harms during treatment also matter. These details help explain whether a study has something useful to say about a symptom.
Distinguishes skin creams, supplements, and prescription medicines
Peptides can affect how cells work, but their effects differ from one substance to another. Semaglutide imitates a gut hormone, a substance carrying messages through the body after meals. PT-141 changes brain activity related to interest in sex. GHK-Cu holds copper using three amino acids; those small substances combine to form proteins. NAD+ is not a peptide. Cells use NAD+ while getting energy from food and repairing damage. That work doesn't show that taking extra NAD+ improves a person's health.
A product marked “for research” is offered for experiments, without approval as treatment.
Semaglutide has approved uses as a prescription medicine. Bremelanotide is the medicine's name for PT-141, with approval for a specific desire problem. That approval does not apply to bottles bearing a research label [22]. Such a label cannot tell who used the contents. On cosmetics, Copper Tripeptide-1 means GHK-Cu; the name identifies the cream's ingredient. There is no approved use of GHK-Cu as a swallowed or injected medicine. NAD+ supplements may increase NAD+ in blood without showing whether people lived longer or became healthier [13][17].
Directs weight, skin, energy, and desire questions to the right studies
For weight concerns, the Semaglutide studies describe weight loss and serious illness in large groups. That page also covers heart disease, kidney disease, and reported harms [2][3][4][5]. For skin or hair, the GHK-Cu findings distinguish small human studies from laboratory tests. For tiredness, the NAD+ findings explain why more NAD+ in blood need not mean more energy. For lost desire, the PT-141 findings name the women studied and the changes they reported.
Begin with the problem that led you to look for information.
For any treatment being considered, the doctor can check who or what was tested. People, animals, and cells grown in laboratory dishes provide different kinds of answers. Some skin studies tested mixtures, making a single ingredient's contribution hard to establish. A hoped-for benefit also needs to be weighed against possible harm. The four substances compared puts these differences together. The numbered claims link to their supporting papers. Those papers inform the discussion; your doctor also needs the facts about your health.